ClinicalTrials.Veeva

Menu

Digital Health Promotion for Children With Congenital Heart Disease and Their Guardians

G

German Heart Center Munich

Status

Enrolling

Conditions

Pediatric ALL
Congenital Heart Disease

Treatments

Behavioral: Digital Health Intervention

Study type

Interventional

Funder types

Other

Identifiers

NCT06626672
2024-337-S-SB

Details and patient eligibility

About

Congenital heart disease (CHD) affects approximately 1% of live births, and children with CHD often fail to meet WHO physical activity guidelines. Digital interventions to promote physical activity in CHD patients are limited. This study will develop and test a 12-week digital lifestyle intervention for children (ages 8-13) and their guardians, using a Garmin Vivofit Jr. 2 wearable to continuously monitor physical activity (PA). We will assess its impact on children's moderate to vigorous intensity physical activity (MVPA), daily activity (steps per day), quality of life, nutrition, and health literacy, as well as the quality of life and health literacy of their parents.

Enrollment

60 estimated patients

Sex

All

Ages

8 to 14 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Ages 8-14 years
  • Presence of a congenital heart defect (must be moderate or complex according to ACC criteria)
  • NYHA Class I or II
  • Presence of written informed consent

Exclusion criteria

  • Cognitive impairments that inhibit patients from understanding the tasks
  • No sports clearance by paediatric cardiologists

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

60 participants in 2 patient groups

Digital Health Intervention
Experimental group
Description:
Children and their guardians are given access to a 12-week digital platform with content to improve their lifestyle. Physical activity is monitored with a Garmin Vivofit Jr. 2.
Treatment:
Behavioral: Digital Health Intervention
Control
No Intervention group
Description:
During 12-week control period participants receive no access the digital platform. Physical activity is monitored with a Garmin Vivofit Jr. 2.

Trial contacts and locations

1

Loading...

Central trial contact

Jan Müller, Prof. Dr.; Isabel Uphoff, M.Sc.

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems